An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

NCT02211014 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma (MM)

Interventions

DRUG: acalabrutinib

Sponsor

Acerta Pharma BV

Collaborators

[object Object]